{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T16:40:53Z","timestamp":1793032853293,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.yexcr.2024.114259","type":"journal-article","created":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T02:16:22Z","timestamp":1726452982000},"page":"114259","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Changes and significance of Th1\/Th2 and Treg\/Th17\u00a0cells and their cytokines in patients with alopecia areata"],"prefix":"10.1016","volume":"442","author":[{"given":"Xiaojing","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuming","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenli","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanhui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongmei","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoying","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangzhao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.yexcr.2024.114259_bib1","doi-asserted-by":"crossref","first-page":"74","DOI":"10.7861\/clinmedicine.16-1-74","article-title":"Alopecia in general medicine","volume":"16","author":"Nalluri","year":"2016","journal-title":"Clin. Med."},{"issue":"6","key":"10.1016\/j.yexcr.2024.114259_bib2","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/cup.12698","article-title":"Histopathologic diagnosis of multifactorial alopecia","volume":"43","author":"Wohltmann","year":"2016","journal-title":"J. Cutan. Pathol."},{"key":"10.1016\/j.yexcr.2024.114259_bib3","article-title":"Alopecia areata","volume":"3","author":"Pratt","year":"2017","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.yexcr.2024.114259_bib4","doi-asserted-by":"crossref","first-page":"5966","DOI":"10.1038\/ncomms6966","article-title":"Genome-wide meta-analysis in alopecia areata resolves HLA associations and reveals two new susceptibility loci","volume":"6","author":"Betz","year":"2015","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.yexcr.2024.114259_bib5","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s00251-013-0703-z","article-title":"Association analysis of the HLA-C gene in Japanese alopecia areata","volume":"65","author":"Haida","year":"2013","journal-title":"Immunogenetics"},{"issue":"3","key":"10.1016\/j.yexcr.2024.114259_bib6","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/bjd.14497","article-title":"Alopecia areata and health-related quality of life: a systematic review and meta-analysis","volume":"175","author":"Rencz","year":"2016","journal-title":"Br. J. Dermatol."},{"issue":"3","key":"10.1016\/j.yexcr.2024.114259_bib7","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/jocd.13064","article-title":"Alopecia areata predictive score: a new trichoscopy-based tool to predict treatment outcome in patients with patchy alopecia areata","volume":"19","author":"Waskiel-Burnat","year":"2020","journal-title":"J. Cosmet. Dermatol."},{"key":"10.1016\/j.yexcr.2024.114259_bib8","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jaut.2018.12.001","article-title":"Alopecia areata: a multifactorial autoimmune condition","volume":"98","author":"Simakou","year":"2019","journal-title":"J. Autoimmun."},{"issue":"4","key":"10.1016\/j.yexcr.2024.114259_bib9","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/intimm\/dxw006","article-title":"CD4+ T-cell subsets in inflammatory diseases: beyond the Th1\/Th2 paradigm","volume":"28","author":"Hirahara","year":"2016","journal-title":"Int. Immunol."},{"issue":"12","key":"10.1016\/j.yexcr.2024.114259_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/cells10123397","article-title":"The role of serum Th1, Th2, and Th17 cytokines in patients with alopecia areata: clinical Implications","volume":"10","author":"Waskiel-Burnat","year":"2021","journal-title":"Cells"},{"issue":"11","key":"10.1016\/j.yexcr.2024.114259_bib11","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1111\/ijd.15658","article-title":"IFN-alpha and TNF-alpha serum levels and their association with disease severity in Egyptian children and adults with alopecia areata","volume":"60","author":"Omar","year":"2021","journal-title":"Int. J. Dermatol."},{"issue":"6","key":"10.1016\/j.yexcr.2024.114259_bib12","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/1523-1747.ep12696816","article-title":"Lymphotoxin, tumor necrosis factor, and gamma interferon are cytostatic for normal human keratinocytes","volume":"92","author":"Symington","year":"1989","journal-title":"J. Invest. Dermatol."},{"issue":"11","key":"10.1016\/j.yexcr.2024.114259_bib13","doi-asserted-by":"crossref","first-page":"3252","DOI":"10.1002\/eji.201444646","article-title":"Antigen presenting cell-derived IL-6 restricts Th2-cell differentiation","volume":"44","author":"Mayer","year":"2014","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.yexcr.2024.114259_bib14","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.3389\/fimmu.2019.02318","article-title":"The metabolic requirements of Th2 cell differentiation","volume":"10","author":"Stark","year":"2019","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.yexcr.2024.114259_bib15","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.4168\/aair.2020.12.6.1029","article-title":"Aberrant Th2 immune responses are associated with a reduced frequency of IL-35-induced regulatory T cells after allergen exposure in patients with allergic asthma","volume":"12","author":"Wang","year":"2020","journal-title":"Allergy Asthma Immunol Res"},{"issue":"8","key":"10.1016\/j.yexcr.2024.114259_bib16","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/exd.14129","article-title":"Understanding the significance of cytokines and chemokines in the pathogenesis of alopecia areata","volume":"29","author":"Ito","year":"2020","journal-title":"Exp. Dermatol."},{"issue":"4","key":"10.1016\/j.yexcr.2024.114259_bib17","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1111\/all.15561","article-title":"Scalp biomarkers during dupilumab treatment support Th2 pathway pathogenicity in alopecia areata","volume":"78","author":"Renert-Yuval","year":"2023","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.yexcr.2024.114259_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19030730","article-title":"The balance of Th17 versus Treg cells in autoimmunity","volume":"19","author":"Lee","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.yexcr.2024.114259_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.594735","article-title":"The IL-23\/IL-17 pathway in inflammatory skin diseases: from bench to bedside","volume":"11","author":"Liu","year":"2020","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.yexcr.2024.114259_bib20","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1159\/000350933","article-title":"Alopecia areata: infiltration of Th17 cells in the dermis, particularly around hair follicles","volume":"226","author":"Tanemura","year":"2013","journal-title":"Dermatology"},{"issue":"3","key":"10.1016\/j.yexcr.2024.114259_bib21","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1684\/ejd.2013.2042","article-title":"Cytokine pathways and interactions in alopecia areata","volume":"23","author":"Giordano","year":"2013","journal-title":"Eur. J. Dermatol."},{"issue":"1","key":"10.1016\/j.yexcr.2024.114259_bib22","first-page":"130","article-title":"Alopecia areata is characterized by dysregulation in systemic type 17 and type 2 cytokines, which may contribute to disease-associated psychological morbidity","volume":"182","author":"Bain","year":"2020","journal-title":"Br. J. Dermatol."},{"issue":"6","key":"10.1016\/j.yexcr.2024.114259_bib23","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/ijd.12808","article-title":"T-helper 17 cytokines (interleukins 17, 21, 22, and 6, and tumor necrosis factor-alpha) in patients with alopecia areata: association with clinical type and severity","volume":"55","author":"Atwa","year":"2016","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.yexcr.2024.114259_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1111547","article-title":"The potential of regulatory T cell-based therapies for alopecia areata","volume":"14","author":"Wan","year":"2023","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.yexcr.2024.114259_bib25","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.5114\/ada.2021.112278","article-title":"Comparison of serum concentrations of interleukins 10, 12, 17 and 35 between patients with alopecia areata and controls","volume":"38","author":"Wojciechowska-Zdrojowy","year":"2021","journal-title":"Postepy Dermatol Alergol"},{"issue":"3","key":"10.1016\/j.yexcr.2024.114259_bib26","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jaad.2003.09.032","article-title":"Alopecia areata investigational assessment guidelines--Part II. National Alopecia Areata Foundation","volume":"51","author":"Olsen","year":"2004","journal-title":"J. Am. Acad. Dermatol."},{"issue":"6","key":"10.1016\/j.yexcr.2024.114259_bib27","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.3892\/etm.2017.4312","article-title":"Th1\/Th2 PB balance and CD200 expression of patients with active severe alopecia areata","volume":"13","author":"Ma","year":"2017","journal-title":"Exp. Ther. Med."},{"issue":"3","key":"10.1016\/j.yexcr.2024.114259_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23031038","article-title":"Lifestyle factors involved in the pathogenesis of alopecia areata","volume":"23","author":"Minokawa","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.yexcr.2024.114259_bib29","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.det.2012.08.010","article-title":"Alopecia areata update","volume":"31","author":"Alkhalifah","year":"2013","journal-title":"Dermatol. Clin."},{"issue":"3","key":"10.1016\/j.yexcr.2024.114259_bib30","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1556\/030.62.2015.3.5","article-title":"Study of Th1\/Th2 balance in peripheral blood mononuclear cells of patients with alopecia areata","volume":"62","author":"Sadeghi","year":"2015","journal-title":"Acta Microbiol. Immunol. Hung."},{"issue":"6","key":"10.1016\/j.yexcr.2024.114259_bib31","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/jdv.14775","article-title":"Role of T helper 17 cells and T regulatory cells in alopecia areata: comparison of lesion and serum cytokine between controls and patients","volume":"32","author":"Loh","year":"2018","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"1","key":"10.1016\/j.yexcr.2024.114259_bib32","doi-asserted-by":"crossref","first-page":"63","DOI":"10.5114\/ada.2019.82826","article-title":"Serum concentrations of selected proinflammatory cytokines in children with alopecia areata","volume":"36","author":"Tabara","year":"2019","journal-title":"Postepy Dermatol Alergol"},{"key":"10.1016\/j.yexcr.2024.114259_bib33","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2147\/ITT.S266409","article-title":"Alopecia areata: an autoimmune disease of multiple players","volume":"10","author":"Suchonwanit","year":"2021","journal-title":"ImmunoTargets Ther."},{"issue":"10","key":"10.1016\/j.yexcr.2024.114259_bib34","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/1346-8138.12978","article-title":"Imbalance of T-helper 17 and regulatory T cells in patients with alopecia areata","volume":"42","author":"Han","year":"2015","journal-title":"J. Dermatol."},{"issue":"1","key":"10.1016\/j.yexcr.2024.114259_bib35","doi-asserted-by":"crossref","first-page":"e68","DOI":"10.1111\/pde.13327","article-title":"Pediatric severity of alopecia tool","volume":"35","author":"Bernardis","year":"2018","journal-title":"Pediatr. Dermatol."},{"issue":"4","key":"10.1016\/j.yexcr.2024.114259_bib36","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s13555-022-00711-3","article-title":"Defining severity in alopecia areata: current perspectives and a multidimensional framework","volume":"12","author":"King","year":"2022","journal-title":"Dermatol. Ther."},{"issue":"4","key":"10.1016\/j.yexcr.2024.114259_bib37","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/bjd.18883","article-title":"The Alopecia Areata Investigator Global Assessment scale: a measure for evaluating clinically meaningful success in clinical trials","volume":"183","author":"Wyrwich","year":"2020","journal-title":"Br. J. Dermatol."},{"issue":"1","key":"10.1016\/j.yexcr.2024.114259_bib38","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/jocd.12970","article-title":"The profile of cytokines (IL-2, IFN-gamma, IL-4, IL-10, IL-17A, and IL-23) in active alopecia areata","volume":"19","author":"Gautam","year":"2020","journal-title":"J. Cosmet. Dermatol."},{"issue":"1","key":"10.1016\/j.yexcr.2024.114259_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2019.102429","article-title":"Critical role of interleukin (IL)-17 in inflammatory and immune disorders: an updated review of the evidence focusing in controversies","volume":"19","author":"Ruiz de Morales","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.yexcr.2024.114259_bib40","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.3389\/fimmu.2019.02847","article-title":"Emerging topical and systemic JAK inhibitors in dermatology","volume":"10","author":"Solimani","year":"2019","journal-title":"Front. Immunol."},{"issue":"15","key":"10.1016\/j.yexcr.2024.114259_bib41","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.89790","article-title":"Oral ruxolitinib induces hair regrowth in patients with moderate-to-severe alopecia areata","volume":"1","author":"Mackay-Wiggan","year":"2016","journal-title":"JCI Insight"},{"issue":"6","key":"10.1016\/j.yexcr.2024.114259_bib42","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.jaad.2023.03.041","article-title":"Switching between tofacitinib and baricitinib in alopecia areata: a review of clinical response","volume":"89","author":"Kazmi","year":"2023","journal-title":"J. Am. Acad. Dermatol."},{"issue":"18","key":"10.1016\/j.yexcr.2024.114259_bib43","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1056\/NEJMoa2110343","article-title":"Two phase 3 trials of baricitinib for alopecia areata","volume":"386","author":"King","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.yexcr.2024.114259_bib44","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1684\/ejd.2023.4513","article-title":"Successful management of severe alopecia areata and vitiligo using topical delgocitinib and a 308-nm excimer laser","volume":"33","author":"Murakami","year":"2023","journal-title":"Eur. J. Dermatol."},{"issue":"1","key":"10.1016\/j.yexcr.2024.114259_bib45","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1016\/j.jisp.2017.10.005","article-title":"Cytokine targeted therapeutics for alopecia areata: lessons from atopic dermatitis and other inflammatory skin diseases","volume":"19","author":"Malik","year":"2018","journal-title":"J. Invest. Dermatol. Symp. Proc."},{"issue":"3","key":"10.1016\/j.yexcr.2024.114259_bib46","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1111\/all.15071","article-title":"Phase 2a randomized clinical trial of dupilumab (anti-IL-4Ralpha) for alopecia areata patients","volume":"77","author":"Guttman-Yassky","year":"2022","journal-title":"Allergy"},{"issue":"5","key":"10.1016\/j.yexcr.2024.114259_bib47","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.jaad.2018.05.032","article-title":"Maintenance of skin clearance with ixekizumab treatment of psoriasis: three-year results from the UNCOVER-3 study","volume":"79","author":"Leonardi","year":"2018","journal-title":"J. Am. Acad. Dermatol."}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482724003501?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482724003501?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T10:17:40Z","timestamp":1736158660000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482724003501"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S0014482724003501"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2024.114259","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Changes and significance of Th1\/Th2 and Treg\/Th17\u00a0cells and their cytokines in patients with alopecia areata","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2024.114259","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114259"}}